IHC screening for EGFR mutations may be useful lung adenocarcinoma diagnosis

  • May 16, 2012

Immunohistochemical screening was linked to a similar predictive value as standard molecular methods in identifying epidermal growth factor receptor mutations that would respond to tyrosine kinase inhibitor therapy in a cohort of patients with lung cancer.Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

  • Lung Cancer Spotlight
  • Greg Otterson, MD
  • Treatment of depression did not alter survival in metastatic lung cancer
  • While patient depression predicted worse survival, early palliative care did not improve survival benefit.
More»
  • Imaging Analysis
  • CT Scan
  • Renal cell carcinoma: A correlation of radiological and pathological findings
  • A step-by-step analysis of image reports from experts in the field.
More»
  • Cover Story
  • Alexis Thompson
  • Worst drug shortage in 30 years prompts fears of permanent scarcity
  • Physicians report between 230 and 270 drugs now in short supply.
More»
  • Physician Insights
  • Greg Otterson, MD
  • B-RAF Targeted Therapies
  • Experts and attendees during HemOnc Today’s Melanoma Meeting in New York to discuss some of the hot topics in melanoma.
More»
HemOnc Today